Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Search
dcp-001
-
search results
If you're not happy with the results, please do another search
Takeda’s milestone payment strengthens BioInvent’s business model
9 April, 2025
BioInvent prepares for a data-rich 2025
3 March, 2025
BioInvent kicks off 2025 with positive clinical data
10 January, 2025
US expansion in focus as BioInvent welcomes new SVP
13 December, 2024
BioInvent anticipates strong influx of clinical data
31 October, 2024
BioInvent’s CMO comments on the ESMO presentation
16 September, 2024
BioInvent makes a strong entrance at ESMO in Barcelona
13 September, 2024
Curasight carries out the first step of capitalization
10 September, 2024
BioInvent anticipates a continued data-rich 2024
2 September, 2024
BioInvent selected to present at ASCO in Chicago
29 April, 2024
BioInvent deepens collaboration with MSD
4 April, 2024
BioInvent expects data from seven clinical studies in 2024
18 January, 2024
BioInvent’s CEO: “This year we made unprecedented progress”
21 December, 2023
Stayble’s new analyses of phase IIb study strengthen disc herniation project
18 December, 2023
BioInvent comments on breast cancer study progress
13 December, 2023
BioInvent is gearing up for clinical data presentations
31 October, 2023
BioInvent achieves research milestone in partnership with Exelixis
8 September, 2023
BioInvent soon has five drug candidates in six clinical studies
1 September, 2023
BioInvent ready for combination studies with BT-001
5 June, 2023
Xintela highlights the unique properties of XSTEM
30 May, 2023
BioInvent’s CFO on the company’s business strategy
9 May, 2023
BioInvent reports clinical progress with BI-1206
21 April, 2023
Mendus steps up the clinical development in 2023
20 April, 2023
Mendus presents NK cell data at the Annual Innate Killer Summit
5 April, 2023
BioInvent’s CEO expects eventful 2023
1 March, 2023
CMO gives insight on new BioInvent collaboration
25 January, 2023
Mendus presents proof-of-concept data in AML maintenance
13 December, 2022
Can Nordic companies extend the life of Keytruda?
1 December, 2022
Regulatory success for BioInvent in the US
21 November, 2022
Strengthened finances and clinical progress for BioInvent in Q3
2 November, 2022
Mendus nears late-stage development with cancer relapse vaccine
24 October, 2022
AstraZeneca builds on the fight against rare diseases
6 October, 2022
BioInvent reaches milestone for BI-1808
8 September, 2022
Mendus in strong position for clinical progress
1 September, 2022
BioInvent sums up eventful Q2
29 August, 2022
Immunicum changes name to Mendus
1 July, 2022
BioInvent in new potentially lucrative license agreement
22 June, 2022
Immunicum delivers positive phase II data in AML
19 May, 2022
Immunicum to present data for potential AML treatment
6 May, 2022
Bioinvent shifts into higher gear
5 May, 2022
Immunicum participates in new cancer research consortium
21 April, 2022
Immunicum’s strategy for fighting tumour recurrence
23 March, 2022
BioInvent presents several projects at AACR’s annual meeting
11 March, 2022
BioInvent delivers in 2021; more to come in 2022
25 February, 2022
BioInvent strengthens the organisation with COO
1 February, 2022
BioInvent’s CMO on the positive FDA decision
21 January, 2022
Immunicum can look back on a transformative 2021
11 January, 2022
Immunicum finalises phase I ILIAD trial
8 December, 2021
Immunicum publishes DCP-001 data
26 November, 2021
Immunicum’s vision for the cancer therapy landscape
3 November, 2021
BioInvent offers guidance on upcoming milestones
3 November, 2021
Eight CEOs on their expectations at BIO-Europe
25 October, 2021
BioInvent’s CEO on the benefits of a diversified portfolio
28 September, 2021
BioStock Studio: Immunicum’s CEO on the company’s new therapeutic focus
13 September, 2021
Immunicum addresses essential challenges in cancer therapy
7 September, 2021
CLS increases focus on clinical studies and strategic collaborations
9 July, 2021
BioStock Studio: Immunicum and DCprime enter immuno-oncology merger
3 July, 2021
Respiratorius recruits experienced Clinical Director
2 July, 2021
CLS strengthens organisation prior to global establishment
4 February, 2021
